Find Academic Supervisors

Fideline Tchuenbou-MagaiaView profile

Senior Lecturer

• Sustainable Technologies
• Formulation Science
• Energy Storage
• +6 more

Dr. Fideline Tchuenbou-Magaia is a Reader in Green Technology at the University of Wolverhampton’s School of Engineering, Faculty of Science and Engineering. She is a multidisciplinary scientist with expertise bridging Chemical Engineering, Biochemistry, and Formulation Science. Her academic journey includes a PhD in Chemical Engineering from the University of Birmingham (2012), a Master’s in Food Science and Technology from Agro ParisTech (2006), and a BSc in Biochemistry from the University of Douala (2001). Key research areas: Sustainable formulation engineering, Cold energy storage, Carbon capture, and IoT applications in agriculture Leading Energy and Green Technologies Research Group Active in product development for industry (Nestle, PepsiCo, Micreos) Publications span waste valorisation, smart packaging, battery systems, and sustainable agriculture. Notable grants include £934,275 EPSRC funding for cold energy storage (2015–2019) and over £1 million in Innovate UK/EU energy projects since 2015. Awards include: Nominated for 2021 Vice-Chancellor's Awards Student Union Teaching Awards (2020, 2021) Lecturer of the Year (2020) She supervises doctoral students in topics ranging from Metal Organic Frameworks for carbon capture to Smart packaging and battery safety , and serves as External Examiner at multiple UK universities. Her work integrates food, energy, and environmental systems toward a circular economy.

• Pharmaceutical Chemistry
• Drug Delivery Systems
• Polymer Chemistry
• +3 more

Mariano Licciardi is a Full Professor at the Department of Biological, Chemical and Pharmaceutical Sciences and Technologies within the School of Basic and Applied Sciences at the University of Palermo (UNIPA). His research focuses on advanced pharmaceutical technology, drug delivery systems, and polymer/nanotechnology applications in biomedical contexts. Primary Affiliation: University of Palermo Academic Role: Full Professor Department: Biological, Chemical and Pharmaceutical Sciences and Technologies Research Areas: Pharmaceutical Chemistry, Nanotechnology, Tissue Engineering, Biomedical Delivery Systems His work emphasizes stimuli-responsive drug delivery , biodegradable scaffolds , and magnetic nanocarriers for targeted therapies. Publications highlight innovations in electrospun membranes , microparticle engineering , and polymer-brush systems for ocular, bone, and cancer treatments. While the provided data lacks explicit awards or student lists, his academic activity includes teaching courses like Applied Pharmaceutical Technology and supervising research projects.

Joshua EixenbergerView profile

Academic

• Nanoparticle Research
• Graphene
• ZnO Material Science
• +7 more

Joshua Eixenberger is an Assistant Research Professor with the Department of Physics at Boise State University and also affiliated with the Micron School of Materials Science and Engineering. Previously, he worked as a research scientist with the Center for Advanced Energy Studies. Educational Background: Doctorate in Biomolecular Sciences, Boise State University Master of Science in Biomolecular Sciences, Boise State University B.S. in Applied Mathematics, Boise State University B.S. in Physics, Boise State University Dr. Eixenberger's research spans multiple disciplines at the intersection of materials science, nanotechnology, and biomedical engineering. His work focuses on the development and application of novel nanomaterials, particularly graphene, MXenes, and ZnO nanoparticles, for applications ranging from energy harvesting and storage to drug delivery and tissue engineering. His research fingerprint shows strong activity in nanoparticle research (100%), ZnO material science (38%), gold nanoparticles (37%), graphene (33%), three-dimensional printing (32%), magnetic properties (29%), nanostructured materials (28%), and sintering (22%). His work contributes to several UN Sustainable Development Goals related to clean energy and good health. His recent publications demonstrate a strong emphasis on printed electronics, additive manufacturing of nanomaterials, and the development of novel bioscaffolds for tissue engineering applications. His research shows a progression from fundamental nanomaterials properties to applied research in energy, electronics, and biomedical applications, with increasing publication output in recent years. Scientific Contributions: Development of graphene foam bioscaffolds for tissue engineering with electrical stimulation capabilities Formulation of MXene inks for printed electronics and energy storage devices Research on ZnO nanoparticles for controlled drug delivery applications Development of copper-plated laser-induced graphene for flexible hybrid electronic applications Nuclear sensor development and instrumentation Dr. Eixenberger has published 44 research outputs since 2013 with an h-index of 10 and 474 citations. His work has been featured in multiple news outlets and has garnered attention in academic circles as evidenced by Mendeley readership and social media mentions.

• Gene Therapy
• Neurology
• Genetic Disorders
• +5 more

Genevieve A Laforet, MD, PhD is an Assistant Professor in the Department of Genetic and Cellular Medicine at UMass Chan Medical School's T.H. Chan School of Medicine. Her research spans gene therapy, neurology, and genetic disorders with a focus on translational applications. She maintains an active research program with publications spanning from 2006 to 2025, demonstrating sustained scholarly productivity in her field. Education: BA in Biochemical Sciences from Harvard University MD from Duke University PhD in Bioorganic Chemistry & Biochemistry from The Rockefeller University Dr. Laforet's research interests center on gene therapy applications for neurological disorders, with particular emphasis on Canavan disease and other rare genetic conditions. Her work bridges basic science and clinical applications, focusing on biomarker development, therapeutic interventions, and assessment methodologies. Recent publications indicate a growing focus on gene therapy safety concerns, particularly regarding thrombotic microangiopathy associated with viral vector delivery systems. Analysis of her publication history reveals a consistent trajectory from neurological disorders (particularly multiple sclerosis and migraine in earlier work) toward genetic disorders and gene therapy applications in more recent years. The 2024-2025 publications demonstrate a strong focus on Canavan disease biomarkers and gene therapy safety, suggesting this has become her primary research concentration. Her work frequently involves pediatric populations and incorporates both biochemical and clinical assessment approaches. Dr. Laforet collaborates extensively with researchers across multiple institutions, as evidenced by her co-authorship patterns. While specific grant information isn't provided in the available materials, her publication record suggests involvement in NIH-funded research given the nature of her work in rare genetic disorders and gene therapy. Her laboratory or research group appears to focus on translational neuroscience with particular expertise in N-acetylaspartate metabolism, gene therapy vector development, and clinical assessment methodologies for neuromuscular disorders. The 2025 publications suggest ongoing work in remote assessment technologies for pediatric neurological conditions.

Begona Delgado-CharroView profile

Professor

• Transdermal Drug Delivery
• Topical Drug Delivery
• Nail Disease Treatment
• +4 more

Begona Delgado-Charro is a Professor in the Department of Life Sciences at the University of Bath. She leads cutting-edge research in transdermal and topical drug delivery, with a focus on nail disease treatment (e.g., onychomycosis, psoriasis), non-invasive therapeutic drug monitoring, and mathematical modeling of skin absorption. Her work spans formulation development, in vitro-in vivo correlations, and transport mechanism analysis. Principal Investigator for projects including "Multi-functional Dermal PBPK Modeling" (2023-2025) and "Microneedle Insertion Optimization" (EPSRC-funded, 2021-2025) Key collaborator in "Skin Pharmacokinetics of Topical Drugs" (2018-2025) with Prof. Richard Guy and Dr. Jonathan White Research Pillars: • Transdermal delivery of drugs (SERMs, corticosteroids, antifungals) • Mathematical modeling of skin reservoir formation and drug flux • Pediatric drug delivery and non-invasive sampling kinetics Funded by the Leo Foundation, UK Medical Research Council, NHS-NIC, US-FDA, and The Academy of Medical Sciences Scientific Contributions: Her 166+ research outputs include innovations in: - Reverse iontophoresis for lithium/glucose monitoring (Clin. Chem. 2004) - Nanoparticle disposition in skin (J. Control. Release 2012) - Microneedle-porated nail delivery systems (J Control. Release 2015) - Bioequivalence methodologies for topical products (Pharm Res 2017) Network Impact: Her work intersects with UN Sustainable Development Goals (SDG 3: Good Health & Well-being). She collaborates internationally on iontophoresis (100% research focus), transdermal delivery (39%), and bioavailability (30%).

David A. PutnamView profile

Professor

• Drug Delivery and Nanomedicine
• Polymers and Soft Matter
• Mechanics of Biological Materials
• +7 more

David A. Putnam is a Professor in the Department of Biomedical Engineering at Cornell University's College of Engineering, where he has been a faculty member since 2002. His research focuses on designing functional biomaterials using organic polymer chemistry and molecular biology to address critical challenges in human health, including drug delivery systems, vaccine development, and synthetic lubricants for medical applications. His educational background includes: B.S. in Pharmacy from Albany College of Pharmacy at Union University (1990) Ph.D. in Pharmaceutical Chemistry from the University of Utah (1996) NIH Postdoctoral Fellowship in Chemical Engineering at MIT under Professor Robert Langer (1996-1999) Putnam's research spans drug delivery and nanomedicine, polymers and soft matter, mechanics of biological materials, and tissue engineering. His work integrates chemical synthesis with biological principles to develop innovative solutions such as vaccine adjuvants, surgical biomaterials, and arthritis treatments. He has pioneered approaches in polymeric vector design and biomaterial synthesis for medical applications. His publication record from 2006-2010 reveals a strong emphasis on translational biomaterials research, with recurring themes in polymer chemistry for drug/gene delivery, surgical applications, and vaccine development. These works demonstrate his expertise in bridging fundamental polymer science with clinical needs through systematic material design. His scientific accolades include: Fellow of AIMBE (top 2% of U.S. biomedical engineers) and Coulter Foundation Cornell's Fiona Ip Li '78 and Donald Li '75 Teaching Excellence Award (2010) Michaelson Grant from Found Animals Foundation (2014) Invited speaker at Keystone Symposium (2015) Editorial roles for seven journals including Pharmaceutical Research and Journal of Controlled Release Putnam secures major research funding from NIH, NSF, Coulter Foundation, and Department of Defense. He co-founded TransForm Pharmaceuticals (acquired by Johnson & Johnson in 2005) and served as Entrepreneur-in-Residence at PureTech Ventures. He led an interdisciplinary NSF-funded $2M project developing biosynthetic lubricants for arthritis treatment and actively participates in Cornell's BioEntrepreneurship Initiative to commercialize life science innovations. He directs the Putnam Research Group, which focuses on first-principles biomaterial design, and maintains strong industry partnerships while mentoring the next generation of biomedical engineers through Cornell's engineering programs.

• Biochemistry
• Cell Biology
• Cancer Research
• +5 more

Preethy Paul is a Researcher at Åbo Akademi University's Faculty of Natural Sciences and Engineering, affiliated with the Department of Biochemistry and Cell Biology. Her work focuses on health solutions through biochemical research. Email: paul.preethy@abo.fi Research Interests: Preethy Paul specializes in biochemistry and cell biology, with key contributions to the development of anisomelic acid-based treatments for HPV-related carcinomas. Her research spans: Biochemistry Cell biology Cancer research Nanotechnology for drug delivery Pharmacology Computational biology Publication Trends: Over 11 years, her work has focused on anisomelic acid's applications, including cancer therapy (2015-2019) and environmental health (2022). She combines experimental and computational approaches, with collaborations in nanomaterials and pharmaceutical development. Collaborations: Paul has worked with inventors like Eriksson, Rajendran, and Rosenholm on patents related to drug delivery and insect repellents.

• Pharmaceutical Science
• 3D Printing
• Drug Delivery
• +4 more

Rathna Mathiyalagan is an active researcher at the Faculty of Science and Engineering , focusing on pharmacy and health-related solutions. Their work primarily explores 3D printing technologies for veterinary pharmaceutical applications , including tailored drug delivery systems , chewable tablets , and enzyme delivery via nanomaterials . Key collaborations include researchers like X. Wang , N. Sandler , and J. Rosenholm . Their research aligns with the UN Sustainable Development Goals, particularly in global health and advanced pharmaceutical solutions. Recent work involves semi-solid extrusion 3D printing for personalized veterinary dosage forms and mesoporous silica nanoparticles for enzyme delivery in hydrogels. 2025: Dual-release tablets for vomiting treatment 2025: Enzyme delivery in nanocomposite hydrogels 2023: Nanoformed piroxicam for veterinary use 2022: Chewable tablets via portable 3D printing Rathna's publications highlight innovations in pharmaceutical technology and biomedical engineering , with applications in animal health and point-of-care manufacturing .

• Pharmaceutical Technology
• Physical Pharmacy
• 3D Printing in Drug Fabrication
• +2 more

Mirja Palo is a Lecturer at Åbo Akademi University's Faculty of Science and Engineering , specializing in Pharmacy . Her research focuses on pharmaceutical technology, 3D printing in drug fabrication, solid-state characterization, and quality control of drug products. Expertise: 3D printing, electrospinning, wound care materials, veterinary drug delivery Collaborations: Involved in EU-funded AMBioPharma project (2021–2023) Research Trends: Mirja's work bridges pharmaceutical sciences and additive manufacturing, emphasizing personalized dosage forms and sustainable technologies. Recent publications highlight 3D printing for dual-release tablets and electrospun fibers for wound healing.

Nihal AydoganView profile

Professor

• Nanomaterials and Nanotechnology
• Surface Science
• Surfactants
• +3 more

Prof. Dr. Nihal Aydogan is a full-time Professor at Hacettepe University's Chemical Engineering Department, where she has held faculty positions since 2001 (progressing from Assistant to Associate Professor before becoming Professor in 2011). She previously served as Associate Department Head (2007-2010). Her education includes a PhD from the University of Wisconsin-Madison (2001), MS from Middle East Technical University (1996), and BS from Ankara University (1992). She leads the Molecular Nanotechnology and Surface Engineering Research Group . Her research spans nanomaterials, surfactants, colloids, and molecular design, with applications in drug delivery and separation processes. Recent work focuses on: Lipid-based nanocarriers for pulmonary/cancer therapeutics Stimuli-responsive materials (pH/redox-controlled release) Hybrid surfactants for biomedical interfaces Water purification technologies She leads major projects funded by TUBITAK, State Planning Organization (DPT), and L'Oréal, including: Design of high-performance surfactants Nanoparticle engineering for drug delivery Boron removal systems Awards include: Turkish Academy of Sciences Distinguished Young Scientist Award (GEBİP 2007) L'Oréal Turkey Women in Science Fellowship (2007) Hacettepe University Encouragement Award (2007) She has supervised 13+ graduate students (MS/PhD) and maintains collaborations in colloid science and nanomedicine.

• Pharmaceutical Sciences
• Nanotechnology
• Drug Delivery Systems
• +3 more

Jyoti Verma is a researcher at the Faculty of Science and Engineering, Åbo Akademi University, specializing in advanced therapeutic delivery systems. She actively contributes to pharmaceutical sciences and nanotechnology research. Current affiliation: Åbo Akademi University Research focus: Nanoparticle-based drug delivery, toxicity mitigation, and polymer-lipid hybrid systems Research Trends: Her publications since 2015 demonstrate expertise in: Nanocarriers for oncology therapeutics (doxorubicin, docetaxel) Cardiotoxicity reduction strategies for NSAIDs Oral drug delivery optimization using nanostructured systems Computational and experimental validation of plant-based compounds Hybrid nanosystems for improved bioavailability Scientific Contributions: Notable projects include: MADNESS Center of Excellence (2024-2028) - Combatting antimicrobial resistance through materials science Visiting research at University of Tromsø (2023) - Collaborative nanomedicine studies Key Collaborations: Works with Professor Jessica Rosenholm and researchers across Nordic institutions.

• Nanoparticles
• Pharmacology
• Toxicology
• +4 more

Fadak Howaili is a project researcher at the Åbo Akademi Foundation within the Faculty of Science and Engineering , focusing on pharmacy and health-related solutions. Her work intersects materials science, pharmacology, and biomedical engineering. Research Focus : Nanoparticle-based drug delivery systems, photostability of pharmaceutical compounds, and combating antimicrobial resistance through novel materials. Projects : Active participant in the MADNESS project (2024–2028), a multidisciplinary collaboration targeting antimicrobial resistance via materials-driven solutions. Collaborations : Works with researchers like Jessica Rosenholm, Ossi Salo-Ahen, and international partners across pharmacology, materials science, and microbiology. Publications : Published 5 peer-reviewed articles (2022–2025) on topics like enzyme delivery in nanocomposite hydrogels, pH-sensitive nanoparticle coatings, and stability evaluation techniques. UN Sustainable Development Goals : Contributions align with goals targeting health innovation and responsible consumption of pharmaceutical resources.

Karl WaltonView profile

Research Fellow

• Precision Engineering
• Surface Metrology
• Aerodynamics
• +3 more

Karl Walton is a Research Fellow at the Department of Engineering, School of Computing and Engineering, University of Huddersfield. He serves as Acting Head of Department and is affiliated with the Centre for Precision Technologies. His work spans engineering and pharmaceutical sciences, focusing on surface engineering, aerodynamics, and advanced manufacturing techniques. Research Areas: Surface metrology, Mass finishing, Surface analysis, Pharmaceutical materials Key Collaborations: Rolls-Royce, EPSRC Centre for Innovative Manufacturing Walton's research integrates theoretical analysis, experimental validation, and computational modeling. His recent publications demonstrate expertise in composite health monitoring, 3D-printed drug delivery systems, and fatigue failure prediction in machined components. Email: K.Walton@hud.ac.uk

• Sustainable Biomaterials
• Biopolymer Engineering
• Nanocellulose Applications
• +3 more

Xiaoju Wang is a Research Fellow at Åbo Akademi University within the Faculty of Natural Sciences and Technology and Pharmacy department, focusing on sustainable biomaterials derived from plant biopolymers. Research Highlights: Developing bio-enabled nanomaterials using lignin, cellulose, and tannin Creating CO2 capture systems and antimicrobial packaging Expertise in chemical modifications , self-assembled networks , and 3D printing Recent Publications (2024-2025) demonstrate leadership in biomaterial design for pharmaceuticals , wound healing , and carbon capture . Active Collaborations: Leading projects like MADNESS (antimicrobial solutions) and SusCellInk (therapeutic bioinks). Contributing to UN Sustainable Development Goals (SDGs) through material sustainability and health innovations .

Ned B. BowdenView profile

Professor

• Organic Chemistry
• Polymer Science
• Materials Science
• +5 more

Professor Ned B. Bowden is a faculty member in the Department of Chemistry at the University of Iowa . His interdisciplinary research bridges organic chemistry, polymer science, and materials engineering with applications in membrane technology, agricultural productivity, and biomedical innovations . He holds a BS from Caltech, a PhD from Harvard University, and completed postdoctoral research at Stanford University. Current Affiliation: University of Iowa, Department of Chemistry Education: BS (Caltech), PhD (Harvard), Postdoctoral Research Associate (Stanford) Research Focus Bowden’s group develops synthetic solutions for global challenges: organic solvent nanofiltration membranes to revolutionize chemical separation, growth promoters to enhance crop yields for food security, and hydrogen sulfide-releasing compounds for medical applications targeting cancer and ocular diseases. The group emphasizes commercialization , having launched two start-ups. Article Trends His publications span membrane technology (12/15), agricultural chemistry (4/15), and biomedical engineering (5/15), with recurring themes of cross-linked polymers , thiol-based chemistry , and controlled release mechanisms . Recent work (2020–2024) prioritizes epoxy membranes and H2S delivery systems . Grants and Collaborations In 2023, his team secured an NSF grant for membrane purification of fatty acids. Collaborations extend to pharmacy, biomedical engineering, neurosurgery, and agricultural science , reflecting his interdisciplinary approach. Advising and Lab Dynamics Bowden has mentored PhD students Nimesh and Arjun , who defended their theses in 2023, and continues guiding Jett and Vamsi (joined 2024). The lab integrates synthetic chemistry with practical implementation across industries.